Emerging Infectious Diseases (Jan 2023)

Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021

  • Stephanie J. Curtis,
  • Abdul W. Shah,
  • Ana Ratu,
  • Donald J. Wilson,
  • Philip C. Hill,
  • Phil Hulcome,
  • Cathy Gaylard,
  • Daniel Faktaufon,
  • Talica Cabemaiwai,
  • Isireli Rabukawaqa,
  • Tevita Qoriniasi,
  • Akesh Narayan,
  • Susana Nakalevu,
  • Pablo Romakin,
  • Jemesa Tudravu,
  • James Fong,
  • Nick Walsh

DOI
https://doi.org/10.3201/eid2901.221514
Journal volume & issue
Vol. 29, no. 1
pp. 226 – 228

Abstract

Read online

During November–December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8–70 years of age were 95.5% (95% CI 93.4%–97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.

Keywords